100 related articles for article (PubMed ID: 30912200)
21. The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.
Wu X; Zhou F; Ji X; Ren K; Shan Y; Mao X; Fen Y; Chen R; Ding H; Fu X
Future Oncol; 2017 Dec; 13(29):2691-2696. PubMed ID: 28972404
[TBL] [Abstract][Full Text] [Related]
22. [Bioinformatics analysis of expression and function of EXD3 gene in gastric cancer].
Sun D; Liu M; Huang F; Huang F
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):215-221. PubMed ID: 30890511
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer.
Qi M; Liu D; Zhang S
Cancer Biomark; 2017; 18(4):451-458. PubMed ID: 28128744
[TBL] [Abstract][Full Text] [Related]
24. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
25. [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].
Liu YP; Ling Y; Zhang YP; Liu BR
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):256-9. PubMed ID: 21418871
[TBL] [Abstract][Full Text] [Related]
26. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
27. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence.
Li F; Wang NN; Chang X; Wang SL; Wang LS; Yao J; Li ZS; Bai Y
J Dig Dis; 2019 Aug; 20(8):391-400. PubMed ID: 31069993
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
Yu J; Li L; Huang C
Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
32. Gastric Cancer Cell Lines Have Different
Maués JHDS; Ribeiro HF; Pinto GR; Lopes LO; Lamarão LM; Pessoa CMF; Moreira-Nunes CFA; de Carvalho RM; Assumpção PP; Rey JA; Burbano RMR
Can J Gastroenterol Hepatol; 2018; 2018():5804376. PubMed ID: 30410872
[No Abstract] [Full Text] [Related]
33. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
Dressman HK; Berchuck A; Chan G; Zhai J; Bild A; Sayer R; Cragun J; Clarke J; Whitaker RS; Li L; Gray J; Marks J; Ginsburg GS; Potti A; West M; Nevins JR; Lancaster JM
J Clin Oncol; 2007 Feb; 25(5):517-25. PubMed ID: 17290060
[TBL] [Abstract][Full Text] [Related]
34. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.
Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y
Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019
[TBL] [Abstract][Full Text] [Related]
35. Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis.
Zhang X; Wei X; Bai G; Huang X; Hu S; Mao H; Liu P
Cancer Manag Res; 2021; 13():8629-8646. PubMed ID: 34824550
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.
Zhang Y; Li Q; Yu S; Zhu C; Zhang Z; Cao H; Xu J
Biochem Biophys Res Commun; 2019 Feb; 509(3):753-762. PubMed ID: 30638658
[TBL] [Abstract][Full Text] [Related]
37. Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy.
Li YQ; Yin JY; Liu ZQ; Li XP
IUBMB Life; 2018 Mar; 70(3):183-191. PubMed ID: 29394468
[TBL] [Abstract][Full Text] [Related]
38. MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.
Pénzváltó Z; Lánczky A; Lénárt J; Meggyesházi N; Krenács T; Szoboszlai N; Denkert C; Pete I; Győrffy B
BMC Cancer; 2014 Nov; 14():837. PubMed ID: 25408231
[TBL] [Abstract][Full Text] [Related]
39. An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023.
Shoji T; Komiyama S; Kigawa J; Tanabe H; Kato K; Itamochi H; Fujiwara H; Kamiura S; Hamano T; Sugiyama T;
BMC Cancer; 2018 Jul; 18(1):771. PubMed ID: 30064406
[TBL] [Abstract][Full Text] [Related]
40. Discovery of signature genes in gastric cancer associated with prognosis.
Zhao X; Cai H; Wang X; Ma L
Neoplasma; 2016; 63(2):239-45. PubMed ID: 26774142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
